$1.16
-0.01 (-0.85%)
Open$1.17
Previous Close$1.17
Day High$1.18
Day Low$1.16
52W High$1.57
52W Low$0.69
Volume—
Avg Volume123.7K
Market Cap62.55M
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,152.6% upside
Current
$1.16
$1.16
Target
$26.13
$26.13
$16.33
$26.13 avg
$37.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 37.7K | 150.4K | 15.27M |
| Net Income | -18,165,440 | -65,135,043 | 4.70M |
| Profit Margin | -51,035.7% | -48,483.9% | 30.8% |
| EBITDA | -17,140,972 | -64,876,188 | 6.30M |
| Free Cash Flow | — | — | 4.04M |
| Rev Growth | -74.9% | -74.9% | -3.4% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |